Related by context. Frequent words. (Click for all words.) 84 BioGlue R 67 FDA Accepts 67 Ranexa R 67 Receives Orphan Drug Designation 66 product GEM #S 66 ranolazine extended release 66 Application BLA 66 Generic Version 66 Subcutaneous Use 66 Oral Solution 65 Completes Enrollment 65 Release Tablets 65 Lubiprostone 65 Announces FDA Clearance 64 Patient Enrollment 64 Testim R 64 R bortezomib 64 Panzem R 64 injection USP 64 Coadministration 64 topical anti infective 64 ZALBIN 63 Acetate Rectal Suppositories 63 CHEAP ONLINE PHARMACY LOW 63 Receives FDA Clearance 63 Clevudine 63 developing Zerenex TM 63 Phase III Clinical Trial 63 Application MAA 63 Bone Graft 62 Initiates Phase II 62 BioMarin Genzyme LLC 62 Meets Primary Endpoint 62 Xyntha 62 NASDAQ CRXL 62 submitted Biologics License 62 Extended Release Tablets 62 sodium phosphate monobasic monohydrate 62 Company Nasdaq PRGO 62 CryoSeal FS System 62 Kuvan R 62 * Azixa 62 CRINONE ® 8 62 Aloxi R 61 Voltaren Gel 61 Staff Writer jschramm@minotdailynews.com 61 Nexavar ® 61 AMITIZA R 61 received CE Marking 61 Rectogesic 61 ISTA Pharmaceuticals 61 Presents Positive 61 ABILIFY R 61 Am J Clin 61 Ferumoxytol 61 ZEGERID Powder 61 PINNACLEDIGEST.COM S PAST PERFORMANCE 61 diabetic peripheral neuropathic pain 61 CRINONE R 61 GEM #S 61 NMP# R 61 NEBIDO R 61 Argatroban 61 Inc Therapeutic Competitors 61 R daptomycin 61 pseudobulbar affect PBA 61 Extended Release 60 ZEGERID Capsules 60 Receives CE 60 Transcept Pharmaceuticals 60 Icatibant 60 orthobiologic 60 Pivotal Phase III 60 inhaled formulation 60 Stavzor 60 Act PDUFA date 60 FDA Approval 60 TYGACIL 60 Fenofibrate 60 CE Marked 60 endovascular stent graft 60 VALSTAR 60 Connetics Corporation 60 male hypogonadism licensed 60 Ticagrelor 60 Aradigm Corporation 59 Microspheres 59 SUPPRELIN LA 59 DC Bead 59 By Thomas Gryta 59 PerClot 59 exocrine pancreatic insufficiency 59 TPIAO 59 EntreMed Inc. 59 Azactam 59 CONTAINS FORWARD LOOKING STATEMENTS 59 Pivotal Trial 59 Kepivance 59 VANTAS 59 Nasdaq CRXL 59 wound debridement cosmetic surgery